The uptake and distribution of coenzyme Q(10)

Mitochondrion

Volumn 7, Issue SUPPL., 2007, Pages

  Miles, Michael V ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Absorption; Coenzyme Q(10); Distribution; Pharmacokinetics; Ubiquinone; Uptake

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARNITINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GREEN TEA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PLACEBO; RIBOFLAVIN; THIAMINE; UBIDECARENONE; VITAMIN K GROUP; WARFARIN;

ANTIOXIDANT ACTIVITY; BIOEQUIVALENCE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG COST; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG MONITORING; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DRUG UPTAKE; ENTEROHEPATIC CIRCULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE;

ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS; COENZYMES; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; MODELS, BIOLOGICAL; OXYGEN; PHOSPHORYLATION; RATS; TIME FACTORS; TISSUE DISTRIBUTION; UBIQUINONE;

ANIMALIA;

EID: 34248188655     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2007.02.012     Document Type: Review

References (71)

1. Ashida Y., Yamanishi H., Terada T., Oota N., Sekine K., and Watabe K. CoQ10 supplementation elevates the epidermal CoQ10 level in adult hairless mice. Biofactors 25 (2005) 175-178
2. Balercia G., Mosca F., Mantero F., Boscaro M., Mancini A., Ricciardo-Lamonica G., and Littarru G. Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil. Steril. 81 (2004) 93-98
3. Bhagavan H.N., Chopra R.K., Craft N.E., Chitchumroonchokchai C., and Failla M.L. Assessment of coenzyme Q10 absorption using an in vitro digestion-Caco-2 cell model. Int. J. Pharm. (2007) Epub ahead of print
4. Bresolin N., Doriguzzi C., Ponzetto C., Angelini C., Moroni I., Castelli E., Cossutta E., Binda A., Gallanti A., Gabellini S., Piccolo G., Martinuzzi A., Ciafaloni E., Arnaudo E., Liciardello L., Carenzi A., and Scarlato G. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J. Neurol. Sci. 100 (1990) 70-78
5. Chinnery P., Majamaa K., Turnbull D., and Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. Jan 25 1 (2006) CD004426
6. Chopra R.K., Goldman R., Sinatra S.T., and Bhagavan H.N. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int. J. Vitam. Nutr. Res. 68 (1998) 109-113
7. Costeff H., Apter N., Elpeleg O.N., Prialnic M., and Bohles H.J. Ineffectiveness of oral coenzyme Q10 supplementation in 3-methylglutaconic aciduria, type 3. Brain Dev. 20 (1998) 33-35
8. Elmberger P.G., Kalen A., Brunk U.T., and Dallner G. Discharge of newly-synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile. Lipids 24 (1989) 919-930
9. Fernandez-Ayala D.J., Brea-Calvo G., Lopez-Lluch G., and Navas P. Coenzyme Q distribution in HL-60 human cells depends on the endomembrane system. Biochim. Biophys. Acta 1713 (2005) 129-137
10. Fernandez-Ayala D.J., Lopez-Lluch G., Garcia-Valdes M., Arroyo A., and Navas P. Specificity of coenzyme Q10 for a balanced function of respiratory chain and endogenous ubiquinone biosynthesis in human cells. Biochim. Biophys. Acta 1706 (2005) 174-183
11. Ferrante K.L., Shefner J., Zhang H., Betensky R., O'Brien M., Yu H., Fantasia M., Taft J., Beal M.F., Traynor B., Newhall K., Donofrio P., Caress J., Ashburn C., Freiberg B., O'Neill C., Paladenech C., Walker T., Pestronk A., Abrams B., Florence J., Renna R., Schierbecker J., Malkus B., and Cudkowicz M. Tolerance of high-dose (3000 mg/day) coenzyme Q10 in ALS. Neurology 65 (2005) 1834-1836
12. Geng A.L., and Guo Y.M. Effects of dietary coenzyme Q10 supplementation on hepatic mitochondrial function and the activities of respiratory chain-related enzymes in ascitic broiler chickens. Br. Poult. Sci. 46 (2005) 626-634
13. Gvozdjakova A., Kucharska J., Bartkovjakova M., Gazdikova K., and Gazdik F.E. Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma. Biofactors 25 (2005) 235-240
14. Groneberg D.A., Kindermann B., Althammer M., Klapper M., Vormann J., Littarru G.P., and Doring F. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int. J. Biochem. Cell Biol. 37 (2005) 1208-1218
15. Hathcock J.N., and Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul. Toxicol. Pharmacol. 45 (2006) 282-288
16. Hargreaves I.P., Duncan A.J., Heales S.J., and Land J.M. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. Drug Saf. 28 (2005) 659-676
17. Henriksen J.E., Andersen C.B., Hother-Nielsen O., Vaag A., Mortensen S.A., and Beck-Nielsen H. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet. Med. 16 (1999) 312-318
18. Hofman-Bang C., Rehnqvist N., Swedberg K., Wiklund I., Astrom H., and The Q10 Study Group. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. J. Card. Fail. 1 (1995) 101-107
19. Horkovics-Kovats S. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability. Arzneim.-Forsch. Drug Res. 49 II (1999) 805-815
20. Horvath R., Schneiderat P., Schoser B.G., Gempel K., Neuen-Jacob E., Ploger H., Muller-Hocker J., Pongratz D.E., Naini A., DiMauro S., and Lochmuller H. Coenzyme Q10 deficiency and isolated myopathy. Neurology 66 (2006) 253-255
21. Hosoe K., Kitano M., Kishida H., Kubo H., Fujii K., and Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH™) after single and 4-week multiple oral administration to healthy volunteers. Regul. Toxicol. Pharmacol. 47 (2007) 19-28
22. Huntington Study Group, 2001. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology 57, 397-404.
23. Ikematsu H., Nakamura K., Harashima S., Fujii K., and Fukutomi N. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial. Regul. Toxicol. Pharmacol. 44 (2006) 212-218
24. Isobe C., Murata T., Sato C., and Terayama Y. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease. J. Clin. Neurosci. (2006) Apr 27; Epub ahead of print
25. Kaikkonen J., Tuomainen T.P., Nyyssonen K., and Salonen J.T. Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels. Free Radic. Res. 36 (2002) 389-397
26. Kamzalov S., Sumien N., Forster M.J., and Sohal R.S. Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice. J. Nutr. 133 (2003) 3175-3180
27. Khatta M., Alexander B.S., Krichten C.M., Fisher M.L., Freudenberger R., Robinson S.W., and Gottlieb S.S. The effect of coenzyme Q10 in patients with congestive heart failure. Ann. Intern. Med. 132 (2000) 636-640
28. Klongpanichapak S., Govitrapong P., Sharma S.K., and Ebadi M. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10. Neurochem. Res. 31 (2006) 303-311
29. Kommuru T.R., Gurley B., Khan M.A., and Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 212 (2001) 233-246
30. Kooncumchoo P., Sharma S., Porter J., Govitrapong P., and Ebadi M. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J. Mol. Neurosci. 28 (2006) 125-141
31. Kwong L.K., Kamzalov S., Rebrin I., Bayne A.C., Jana C.K., Morris P., Forster M.J., and Sohal R.S. Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic. Biol. Med. 33 (2002) 627-638
32. Lass A., Forster M.J., and Sohal R.S. Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radic. Biol. Med. 26 (1999) 1375-1382
33. Linnane A.W., Kopsidas G., Zhang C., Yarovaya N., Kovalenko S., Papakostopoulos P., Eastwood H., Graves S., and Richardson M. Cellular redox activity of coenzyme Q10: effect of CoQ10 supplementation on human skeletal muscle. Free Radic. Res. 36 (2002) 445-453
34. Littarru G.P., and Tiano L. Clinical aspects of coenzyme Q10: an update. Curr. Opin. Clin. Nutr. Metab. Care 8 (2005) 641-646
35. Lönnrot K., Holm P., Lagerstedt A., Huhtala H., and Alho H. The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice. Biochem. Mol. Biol. Int. 44 (1998) 727-737
36. Marriage B.J., Clandinin M.T., Macdonald I.M., and Glerum D.M. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol. Genet. Metab. 81 (2004) 263-272
37. Matthews R.T., Yang L., Browne S., Baik M., and Beal M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. USA 95 (1998) 8892-8897
38. Miles M.V., Horn P., Miles L., Tang P., Steele P., and DeGrauw T. Bioequivalence of coenzyme Q10 from OTC supplements. Nutr. Res. 22 (2002) 919-929
39. Miles M.V., Patterson B.J., Schapiro M.B., Hickey F.J., Chalfonte-Evans M., Horn P.S., and Hotze S.L. Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial. Pediatr. Neurol. 35 (2006) 30-37
40. Molyneux S., Florkowski C., Lever M., and George P. The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly. N Z Med. J. 117 (2004) U1108
41. Niklowitz P., Menke T., Andler W., and Okun J.G. Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults. Clin. Chim. Acta 342 (2004) 219-226
42. Niklowitz P., Menke T., Giffei J., and Andler W. Coenzyme Q10 in maternal plasma and milk throughout early lactation. Biofactors 25 (2005) 67-72
43. Palamakula A., Soliman M., and Khan M.M. Regional permeability of coenzyme Q10 in isolated rat gastrointestinal tracts. Pharmazie 60 (2005) 212-214
44. Permanetter B., Rossy W., Klein G., Weingartner F., Seidl K.F., and Blomer H. Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur. Heart J. 13 (1992) 1528-1533
45. Pronzato M.A., Cottalasso D., and Casu A. Quantification of ubiquinone output in bile after interruption of enterohepatic recirculation. Pathologica 80 (1988) 201-205
46. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., and Kumar M.N. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J. Control. Release 113 (2006) 189-207
47. Reahal S., and Wrigglesworth J. Tissue concentrations of coenzyme Q10 in the rat following its oral and intraperitoneal administration. Drug Metab. Dispos. 20 (1992) 423-427
48. Rosenfeldt F.L., Mijch A., McCrystal G., Sweeney C., Pepe S., Nicholls M., and Dennett X. Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy. Int. J. S.T.D. AIDS. 16 (2005) 827-829
49. Sander S., Coleman C.I., Patel A.A., Kluger J., and White C.M. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J. Card. Fail. 12 (2006) 464-472
50. Santos-Ocana C., Do T.Q., Padilla S., Navas P., and Clarke C.F. Uptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast CoQ mutants. J. Biol. Chem. 277 (2002) 10973-10981
51. Scalori V., Alessandri M.G., Giovannini L., and Bertelli A. Plasma and tissue concentrations of coenzyme Q10 in the rat after intravenous, oral and topical administrations. Int. J. Tissue React. 12 (1990) 149-154
52. Sekine K., Ota N., Nishii M., Uetake T., and Shimadzu M. Estimation of plasma and saliva levels of coenzyme Q10 and influence of oral supplementation. Biofactors 25 (2005) 205-211
53. Sharma S.K., El Refaey H., and Ebadi M. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10. Brain Res. Bull. 70 (2006) 22-32
54. Shults C.W., Beal M.F., Fontaine D., Nakano K., and Haas R.H. Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. Neurology 50 (1998) 793-795
55. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Kurlan R., Molho E., Harrison M., Lew M., and Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59 (2002) 1541-1550
56. Shults C.W., Beal M.F., Song D., and Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp. Neurol. 188 (2004) 491-494
57. Sohal R.S. Coenzyme Q and vitamin E interactions. Methods Enzymol. 378 (2004) 146-151
58. Somayajulu M., McCarthy S., Hung M., Sikorska M., Borowy-Borowski H., and Pandey S. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by coenzyme Q10. Neurobiol. Dis. 18 (2005) 618-627
59. Steele P.E., Tang P.H., DeGrauw A.J., and Miles M.V. Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. Am. J. Clin. Pathol. 121 Suppl. (2004) S113-S120
60. Strijks E., Kremer H.P., and Horstink M.W. Q10 therapy in patients with idiopathic Parkinson's disease. Mol. Aspects Med. 18 Suppl. (1997) S237-S240
61. Teran E., Vivero S., Racines-Orbe M., Castellanos A., Chuncha G., Enriquez G., and Moya W. Coenzyme Q10 is increased in placenta and cord blood during preeclampsia. Biofactors 25 (2005) 153-158
62. Tomasetti M., Alleva R., Solenghi M.D., and Littarru G.P. Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 9 (1999) 231-240
63. Tomono Y., Hasegawa J., Seki T., Motegi K., and Morishita N. Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. Int. J. Clin. Pharmacol. Ther. Toxicol. 24 (1986) 536-541
64. Upaganlawar A., Farswan M., Rathod S., and Balaraman R. Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats. Indian J. Exp. Biol. 44 (2006) 416-418
65. Weber C., Bysted A., and Holmer G. Coenzyme Q10 in the diet--daily intake and relative bioavailability. Mol. Aspects Med. 18 Suppl. (1997) S251-S254
66. Weis M., Mortensen S.A., Rassing M.R., Moller-Sonnergaard J., Poulsen G., and Rasmussen S.N. Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers. Mol. Aspects Med. 15 Suppl. (1994) s273-s280
67. Wojcik M., Bobowiec R., Martelli F., and Gazzano A. The response of bile secretion and ubiquinone Q10 to hyperglycaemia in sheep. Pol. J. Vet. Sci. 6 (2003) 183-188
68. Yen D.H., Chan J.Y., Huang C.I., Lee C.H., Chan S.H., and Chang A.Y. Coenzyme Q10 confers cardiovascular protection against acute mevinphos intoxication by ameliorating bioenergetic failure and hypoxia in the rostral ventrolateral medulla of the rat. Shock 23 (2005) 353-359
69. Yuzuriha T., Takada M., and Katayama K. Transport of [14C]-coenzyme Q10 from the liver to other tissues after intravenous administration to guinea pigs. Biochim. Biophys. Acta 759 (1983) 286-291
70. Zhang Y., Aberg F., Appelkvist E.L., Dallner G., and Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 125 (1995) 446-453
71. Zhou Q., Zhou S., and Chan E. Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes. Curr. Drug Metab. 6 (2005) 67-681